Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07508917
PHASE1/PHASE2

Effects of 5-Methyltetrahydrofolic Acid Supplementation on Maternal Health and One-Carbon Metabolism During Lactation

Sponsor: Fundació Sant Joan de Déu

View on ClinicalTrials.gov

Summary

This double-blind, randomized, placebo-controlled parallel trial evaluates the effects of maternal 5-methyltetrahydrofolate (5-MTHF) supplementation during breastfeeding. Thirty-six lactating mother-infant dyads will be randomized (1:1) to receive 5-MTHF or placebo for 6 weeks, stratified by infant sex and mode of delivery. Tolerability and adverse events will be monitored. Pre- and post-intervention assessments include breast milk one-carbon metabolites and oligosaccharides; maternal plasma one-carbon metabolites and metabolic health markers. Maternal mental health will be evaluated using the SCL-90-R questionnaire. A follow-up visit at 4 months will reassess infant anthropometry and microbiome outcomes.

Key Details

Gender

FEMALE

Age Range

18 Years - 42 Years

Study Type

INTERVENTIONAL

Enrollment

36

Start Date

2026-04-15

Completion Date

2027-02-28

Last Updated

2026-04-02

Healthy Volunteers

No

Conditions

Interventions

DIETARY_SUPPLEMENT

5-MTHF Supplementation

Oral supplementation with 5-MTHF (800 µg) administered daily for 6 weeks during lactation.

OTHER

Placebo

Matching placebo administered daily for 6 weeks during lactation.

Locations (2)

Hospital Sant Joan de Deu

Barcelona, Barcelona, Spain

Hospital Sant Joan de Déu

Barcelona, Barcelona, Spain